L40.0 L20.8
Conditions
Interventions
Group 1: The forthcoming study is an adaptation of the randomised pilot study (Psychoeducational schema therapy for psoriasis and atopic dermatitis: a randomised controlled pilot crossover trial. JDts
1-10. https://doi.org/10.1111/ddg.70020). The aim is to evaluate the three shortened, manualised sessions, each lasting 15 minutes. The sessions will be conducted by trained dermatologists from the In
Sponsors
UKSH Kiel
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Physician diagnosed psoriasis vulgaris or atopic dermatitis for more than 3 months, DLQI >= 5, PHQ-4 >= 3
Exclusion criteria
Exclusion criteria: Insufficient proficiency in written and spoken German, diagnosed depression, severe psychiatric disorders, pregnancy, lactation, adults lacking the capacity to provide informed consent, acute suicidality, and current substance use disorder (including alcohol and drug abuse).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endpoint: Chance in PHQ-4 and PHQ-9 (Patient Health Questionaire-2, -9) GAD-7 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Dermatology Life Quality Index (DLQI) , Well- Being Index (WHO-5) | — |
Countries
Germany
Contacts
Public ContactSascha Gerdes
UKSH
Outcome results
None listed